Hubei Retained Earnings vs Accounts Payable Analysis

600566 Stock

30.10 0.26 0.87%

Hubei Jumpcan financial indicator trend analysis is much more than just examining Hubei Jumpcan Pharma latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Hubei Jumpcan Pharma is a good investment. Please check the relationship between Hubei Jumpcan Retained Earnings and its Accounts Payable accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Hubei Jumpcan Pharmaceutical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Retained Earnings vs Accounts Payable

Retained Earnings vs Accounts Payable Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Hubei Jumpcan Pharma Retained Earnings account and Accounts Payable. At this time, the significance of the direction appears to have almost identical trend.

The correlation between Hubei Jumpcan's Retained Earnings and Accounts Payable is 0.95. Overlapping area represents the amount of variation of Retained Earnings that can explain the historical movement of Accounts Payable in the same time period over historical financial statements of Hubei Jumpcan Pharmaceutical, assuming nothing else is changed. The correlation between historical values of Hubei Jumpcan's Retained Earnings and Accounts Payable is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Retained Earnings of Hubei Jumpcan Pharmaceutical are associated (or correlated) with its Accounts Payable. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Accounts Payable has no effect on the direction of Retained Earnings i.e., Hubei Jumpcan's Retained Earnings and Accounts Payable go up and down completely randomly.

Correlation Coefficient

0.95

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Retained Earnings

The cumulative amount of net income that a company retains for reinvestment in its operations, rather than distributing it to shareholders as dividends.

Accounts Payable

An accounting item on the balance sheet that represents Hubei Jumpcan obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Hubei Jumpcan Pharma are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Most indicators from Hubei Jumpcan's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Hubei Jumpcan Pharma current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Hubei Jumpcan Pharmaceutical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

The current year's Selling General Administrative is expected to grow to about 4.1 B, whereas Tax Provision is forecasted to decline to about 298.4 M.

	2021	2022	2023	2024 (projected)
Operating Income	1.7B	2.3B	2.9B	3.0B
Total Revenue	7.6B	9.0B	9.7B	10.1B

Operating Income Total Revenue

Hubei Jumpcan fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Retained Earnings	Accounts Payable	Cash	Long Term Debt	Net Receivables	Inventory	Other Current Assets	Total Liab	Intangible Assets	Common Stock	Property Plant Equipment	Short Term Investments	Other Assets	Net Tangible Assets	Good Will	Deferred Long Term Liab	Long Term Investments	Total Current Assets	Non Current Assets Total	Non Currrent Assets Other	Non Current Liabilities Total
Total Assets		0.25	0.99	1.0	0.98	1.0	0.93	0.97	0.54	0.94	0.96	0.07	0.99	0.83	0.57	0.9	0.92	-0.16	0.89	0.7	0.47	0.78	0.97	0.89	-0.29	0.33
Other Current Liab	0.25		0.12	0.25	0.37	0.18	-0.11	0.02	0.42	0.49	0.26	0.41	0.24	0.59	0.63	0.56	0.01	-0.1	0.34	-0.46	0.51	0.51	0.06	0.52	-0.08	0.61
Total Current Liabilities	0.99	0.12		0.99	0.94	0.99	0.97	0.99	0.54	0.9	0.95	0.02	0.98	0.76	0.53	0.84	0.94	-0.2	0.86	0.77	0.38	0.72	0.98	0.82	-0.29	0.22
Total Stockholder Equity	1.0	0.25	0.99		0.98	1.0	0.93	0.97	0.53	0.94	0.96	0.06	0.99	0.82	0.57	0.89	0.93	-0.16	0.9	0.69	0.48	0.79	0.98	0.89	-0.31	0.31
Other Liab	0.98	0.37	0.94	0.98		0.97	0.84	0.93	0.5	0.93	0.95	0.13	0.97	0.84	0.58	0.93	0.86	-0.12	0.9	0.59	0.6	0.86	0.93	0.95	-0.33	0.41
Retained Earnings	1.0	0.18	0.99	1.0	0.97		0.95	0.98	0.49	0.92	0.96	0.05	0.99	0.8	0.52	0.87	0.93	-0.16	0.89	0.73	0.42	0.77	0.99	0.87	-0.33	0.28
Accounts Payable	0.93	-0.11	0.97	0.93	0.84	0.95		0.98	0.43	0.79	0.88	-0.08	0.92	0.62	0.38	0.7	0.95	-0.19	0.78	0.87	0.23	0.59	0.97	0.69	-0.3	0.08
Cash	0.97	0.02	0.99	0.97	0.93	0.98	0.98		0.42	0.84	0.92	-0.04	0.96	0.7	0.42	0.79	0.95	-0.12	0.85	0.82	0.39	0.72	0.99	0.81	-0.32	0.18
Long Term Debt	0.54	0.42	0.54	0.53	0.5	0.49	0.43	0.42		0.69	0.48	0.06	0.56	0.66	0.86	0.67	0.36	-0.62	0.37	0.27	0.29	0.32	0.4	0.39	0.04	0.29
Net Receivables	0.94	0.49	0.9	0.94	0.93	0.92	0.79	0.84	0.69		0.92	0.25	0.95	0.94	0.74	0.97	0.78	-0.32	0.83	0.51	0.45	0.76	0.85	0.88	-0.27	0.49
Inventory	0.96	0.26	0.95	0.96	0.95	0.96	0.88	0.92	0.48	0.92		0.18	0.97	0.83	0.54	0.9	0.84	-0.12	0.84	0.66	0.4	0.76	0.92	0.88	-0.31	0.38
Other Current Assets	0.07	0.41	0.02	0.06	0.13	0.05	-0.08	-0.04	0.06	0.25	0.18		0.1	0.34	0.21	0.29	-0.12	-0.27	0.08	-0.18	-0.02	0.09	-0.02	0.26	-0.27	0.43
Total Liab	0.99	0.24	0.98	0.99	0.97	0.99	0.92	0.96	0.56	0.95	0.97	0.1		0.83	0.58	0.91	0.9	-0.17	0.87	0.71	0.45	0.76	0.96	0.89	-0.24	0.4
Intangible Assets	0.83	0.59	0.76	0.82	0.84	0.8	0.62	0.7	0.66	0.94	0.83	0.34	0.83		0.73	0.94	0.57	-0.28	0.72	0.36	0.48	0.73	0.7	0.83	-0.27	0.58
Common Stock	0.57	0.63	0.53	0.57	0.58	0.52	0.38	0.42	0.86	0.74	0.54	0.21	0.58	0.73		0.74	0.37	-0.48	0.62	0.22	0.38	0.62	0.42	0.56	-0.08	0.36
Property Plant Equipment	0.9	0.56	0.84	0.89	0.93	0.87	0.7	0.79	0.67	0.97	0.9	0.29	0.91	0.94	0.74		0.68	-0.25	0.8	0.45	0.6	0.81	0.79	0.93	-0.2	0.63
Short Term Investments	0.92	0.01	0.94	0.93	0.86	0.93	0.95	0.95	0.36	0.78	0.84	-0.12	0.9	0.57	0.37	0.68		-0.05	0.85	0.73	0.34	0.65	0.97	0.72	-0.27	0.05
Other Assets	-0.16	-0.1	-0.2	-0.16	-0.12	-0.16	-0.19	-0.12	-0.62	-0.32	-0.12	-0.27	-0.17	-0.28	-0.48	-0.25	-0.05		-0.06	-0.16	0.21	-0.02	-0.11	-0.02	0.37	0.03
Net Tangible Assets	0.89	0.34	0.86	0.9	0.9	0.89	0.78	0.85	0.37	0.83	0.84	0.08	0.87	0.72	0.62	0.8	0.85	-0.06		0.58	0.46	0.92	0.87	0.87	-0.33	0.25
Good Will	0.7	-0.46	0.77	0.69	0.59	0.73	0.87	0.82	0.27	0.51	0.66	-0.18	0.71	0.36	0.22	0.45	0.73	-0.16	0.58		0.06	0.4	0.78	0.43	-0.14	-0.05
Deferred Long Term Liab	0.47	0.51	0.38	0.48	0.6	0.42	0.23	0.39	0.29	0.45	0.4	-0.02	0.45	0.48	0.38	0.6	0.34	0.21	0.46	0.06		0.58	0.39	0.63	0.1	0.5
Long Term Investments	0.78	0.51	0.72	0.79	0.86	0.77	0.59	0.72	0.32	0.76	0.76	0.09	0.76	0.73	0.62	0.81	0.65	-0.02	0.92	0.4	0.58		0.73	0.91	-0.39	0.4
Total Current Assets	0.97	0.06	0.98	0.98	0.93	0.99	0.97	0.99	0.4	0.85	0.92	-0.02	0.96	0.7	0.42	0.79	0.97	-0.11	0.87	0.78	0.39	0.73		0.82	-0.32	0.19
Non Current Assets Total	0.89	0.52	0.82	0.89	0.95	0.87	0.69	0.81	0.39	0.88	0.88	0.26	0.89	0.83	0.56	0.93	0.72	-0.02	0.87	0.43	0.63	0.91	0.82		-0.29	0.59
Non Currrent Assets Other	-0.29	-0.08	-0.29	-0.31	-0.33	-0.33	-0.3	-0.32	0.04	-0.27	-0.31	-0.27	-0.24	-0.27	-0.08	-0.2	-0.27	0.37	-0.33	-0.14	0.1	-0.39	-0.32	-0.29		0.17
Non Current Liabilities Total	0.33	0.61	0.22	0.31	0.41	0.28	0.08	0.18	0.29	0.49	0.38	0.43	0.4	0.58	0.36	0.63	0.05	0.03	0.25	-0.05	0.5	0.4	0.19	0.59	0.17

Click cells to compare fundamentals

Hubei Jumpcan Account Relationship Matchups

Hubei Jumpcan fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	8.7B	10.5B	12.1B	15.0B	18.1B	19.1B
Other Current Liab	1.2B	1.3B	1.2B	1.3B	47.1M	44.7M
Total Current Liabilities	1.8B	2.0B	2.8B	3.4B	4.6B	4.8B
Total Stockholder Equity	6.1B	7.8B	9.1B	11.3B	13.3B	14.0B
Other Liab	144.2M	183.1M	198.4M	201.2M	231.4M	242.9M
Retained Earnings	3.8B	4.1B	5.4B	7.0B	8.8B	9.3B
Accounts Payable	436.1M	452.5M	705.4M	1.3B	2.1B	2.2B
Cash	2.3B	3.0B	3.8B	4.8B	7.7B	8.1B
Net Receivables	2.1B	1.9B	2.1B	2.8B	2.7B	2.9B
Inventory	338.5M	278.4M	375.6M	391.5M	490.1M	514.6M
Other Current Assets	33.0M	38.1M	58.3M	54.2M	6.9M	6.5M
Total Liab	2.6B	2.8B	3.0B	3.6B	4.8B	5.0B
Intangible Assets	335.8M	283.8M	280.0M	320.6M	315.7M	331.5M
Common Stock	400.2M	436.3M	436.3M	452.7M	520.7M	262.8M
Property Plant Equipment	3.0B	3.1B	3.0B	2.9B	3.3B	3.4B
Short Term Investments	190M	1.3B	1.7B	3.0B	3.2B	3.3B
Other Assets	125.2M	192.8M	198.5M	128.2M	115.4M	128.5M
Net Tangible Assets	5.6B	7.3B	8.7B	10.8B	12.5B	6.5B
Deferred Long Term Liab	4.4M	23.7M	13.2M	3.9M	4.5M	8.1M
Total Current Assets	4.9B	6.6B	8.1B	11.2B	14.2B	14.9B
Non Current Assets Total	3.8B	3.9B	4.0B	3.8B	3.9B	3.9B
Non Currrent Assets Other	31.6M	76.8M	78.6M	15.2M	56.3M	52.6M
Non Current Liabilities Total	720.3M	785.6M	199.4M	201.4M	183.0M	359.6M
Common Stock Shares Outstanding	814.9M	888.3M	888.3M	921.8M	921.8M	952.2M
Other Stockholder Equity	101.6M	100.9M	100.9M	100.8M	90.7M	86.2M
Net Invested Capital	6.7B	8.4B	9.1B	11.7B	14.4B	9.6B
Net Working Capital	3.1B	4.6B	5.3B	7.7B	9.6B	5.5B
Capital Stock	400.2M	436.3M	436.3M	452.7M	452.7M	472.7M

Currently Active Assets on Macroaxis

TITAN	Titan Company Limited
U	Unity Software
PAYC	Paycom Soft
HBI	Hanesbrands
STLD	Steel Dynamics

Other Information on Investing in Hubei Stock

Balance Sheet is a snapshot of the financial position of Hubei Jumpcan Pharma at a specified time, usually calculated after every quarter, six months, or one year. Hubei Jumpcan Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Hubei Jumpcan and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Hubei currently owns. An asset can also be divided into two categories, current and non-current.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Hubei Retained Earnings vs Accounts Payable Analysis

Retained Earnings vs Accounts Payable

Retained Earnings vs Accounts Payable Correlation Analysis

Correlation Coefficient

Retained Earnings

Accounts Payable

Hubei Jumpcan fundamental ratios Correlations

Hubei Jumpcan Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Hubei Jumpcan fundamental ratios Accounts

Currently Active Assets on Macroaxis

Other Information on Investing in Hubei Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Retained Earnings	+ 1.0	Total Assets
Retained Earnings	+ 1.0	Total Stockholder Equity
Total Current Liabilities	+ 0.99	Total Assets
Total Liab	+ 0.99	Total Assets
Total Stockholder Equity	+ 0.99	Total Current Liabilities

Other Assets	- 0.62	Long Term Debt
Other Assets	- 0.48	Common Stock
Good Will	- 0.46	Other Current Liab
Non Currrent Assets Other	- 0.39	Long Term Investments
Non Currrent Assets Other	- 0.33	Net Tangible Assets
Non Currrent Assets Other	- 0.33	Retained Earnings